Latest Bone Stories
The US Drug Watchdog says, "The osteoporosis drug called Fosamax, and out of the blue femur breaks is one of the most complicated issues we have ever encountered. For one, we are hearing from women, who were using Fosamax for five years or more, their femur broke, and typically they had to have at least one surgery to repair the femur. Often, if not in most cases these surgeries involve using a metal rod to reinforce the femur. Our greatest fear is most women, who have had this happen...
Northwestern Medicine expert offer tips for enhancing bone health in early adulthood to avoid osteoporosis in later years CHICAGO, June 11, 2012 /PRNewswire-USNewswire/ -- While women are disproportionately affected by osteoporosis, growing evidence suggests that all adults need to take proactive measures for prevention. Northwestern Medicine® experts say it's important for men to know their risk too and point to a significant amount of evidence that suggests actions to minimize...
Osteochondritis Dissecans is now being treated successfully at The Center for Regenerative medicine in Miami, according to Dr. A. J. Farshchian MD. Miami, FL (PRWEB) June 04, 2012 Osteochondritis Dissecans is now being treated successfully at The Center for Regenerative medicine in Miami, according to Dr. A. J. Farshchian MD. This is typically seen in adolescent males, Osteochondritis Dissecans (OCD) is an entity seen at the ossification centers of the bone (these areas are responsible...
BELGRADE, Mont., May. 30, 2012 /PRNewswire/ -- Bacterin International Holdings, Inc. (NYSE Amex: BONE), a leader in the development of revolutionary bone graft material and antimicrobial coatings for medical applications, will present at the Jefferies 2012 Global Healthcare Conference, in New York, NY, on Thursday, June 7 at 11:00am. Bacterin's presentation will be webcast and available at investor.bacterin.com. About Bacterin International HoldingsBacterin International...
NASA-funded research looks to isotope analysis rather than X-ray for measurement Are your bones getting stronger or weaker? Right now, it's hard to know. Scientists at Arizona State University and NASA are taking on this medical challenge by developing and applying a technique that originated in the Earth sciences. In a new study, this technique was more sensitive in detecting bone loss than the X-ray method used today, with less risk to patients. Eventually, it may find use in clinical...
CAMBRIDGE, Mass., May 22, 2012 /PRNewswire/ -- ETEX Corporation, an advanced biomaterials company, today announced two presentations at the upcoming 9th World Biomaterial Congress, June 1-5, 2012 in Chengdu, China. ETEX will highlight their vertebral augmentation and cell carrier development programs. Dr. Jerry Chang, Head of R&D of ETEX Corporation, will deliver an oral presentation entitled "Enhanced Calcium Phosphate Cements for Vertebral Augmentation" during Rapid Fire...
WASHINGTON, May 15, 2012 /PRNewswire-USNewswire/ -- The National Bone Health Alliance (NBHA), a public-private partnership with 42 member organizations, is urging a simple solution to a big problem: if it's 50+ fracture, request a test. This is the call-to-action for the NBHA's new public and healthcare professional education campaign - 2Million2Many (www.2Million2Many.org). To view the multimedia assets associated with this release, please visit:...
Foundation Urges Patients Not to Stop Treatment without Talking to their Healthcare Provider; Experts Available for Comment WASHINGTON, May 10, 2012 /PRNewswire-USNewswire/ -- In response to the Perspectives pieces published online today by the New England Journal of Medicine, the National Osteoporosis Foundation (NOF), the nation's leading community health organization dedicated to preventing osteoporosis and broken bones, commends the U.S. Food and Drug Administration (FDA) for its...
WASHINGTON, May 10, 2012 /PRNewswire/ -- In response to today's Perspective pieces published in the New England Journal Of Medicine, the National Bone Health Alliance (NBHA), a public-private partnership bringing together the expertise and resources of its 42 members from the private and non-profit sectors to collectively advance bone health and prevent disease, commends the U.S. Food and Drug Administration (FDA) for continuing to investigate the risks and benefits of long-term...
Previous UCSF Research Found Overall Reduction in Spine Fractures, But Not for Other Types of Fractures Continuing a popular but controversial treatment for osteoporosis could reduce spine fracture risk for a particular group of patients, but others could see little to no change if they discontinue it. Based on available evidence, a UCSF researcher reevaluated his 2006 finding from a randomized 10-year study of alendronate, a type of bisphosphonate – a class of drugs that prevent loss of...
